Skip to main content

Valneva SE

VALN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001836564

No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Valneva SE changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of VALN: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders2120−1
Shares3.91M3.78M−127.6K (−3.3%)
Value$24.4M$19.8M−$4.65M (−19.1%)

New holders (6)

Institutions that held Valneva SE at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to VALN in Q2 2026
InstitutionSharesValue% of portfolio
Vivo Capital, LLC763,199$3.99M0.36%
Millennium Management LLC135,223$707.2K0.00%
Citadel Advisors LLC20,294$106.1K0.00%
XTX Topco Ltd15,178$79.4K0.00%
Larson Financial Group LLC375$1.96K0.00%
Caitong International Asset Management Co., Ltd18$940.00%

Sold out (7)

Institutions that held Valneva SE at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of VALN in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Novo Holdings A/S1,057,421$6.61M
HRT Financial LP20,847$130.0K
Old Mission Capital LLC13,759$86.0K
China Universal Asset Management Co., Ltd.5,000$31.3K
EverSource Wealth Advisors, LLC91$569
Clearstead Advisors, LLC48$303
Allworth Financial LP7$44